Brivaracetam Briviact CAS 357336-20-0 Active Pharmaceutical
Product NameBrivaracetam ;
CAS No. 357336-20-0
Molecular Formula C11H20N2O2
Molecular Weight 212.29
Appearance White off-white crystalline powder
Grade Standard Medicine Grade
Appearance White crystal or crystalline powder
Storage Store in well-closed container, protec...
The precise mechanism by which brivaracetam exerts its
antiepileptic activity is unknown. Brivaracetam displays a high and
selective affinity for synaptic vesicle protein 2A (SV2A) in the
brain, which may contribute to the antiepileptic effect.
Brivaracetam is a prescription medication used with other medicines
to treat partial-onset seizures in people 16 years of age and older
with epilepsy. Brivaracetam belongs to a group of drugs called antiepileptics.
These work by reducing the frequency of seizures.
This medication comes in a tablet and solution form and is usually
taken 2 times a day by mouth with or without food. The brivaracetam
tablets should be swallowed whole with liquid. Do not crush or chew
brivaracetam tablets before swallowing.
This medication is also available in an injectable form to be given
directly into a vein (IV) by a healthcare professional.
Excipient information presented when available (limited,
particularly for generics); consult specific product labeling.
Briviact: 50 mg/5 mL (5 mL)
Briviact: 10 mg/mL (300 mL) [contains methylparaben; raspberry
Briviact: 10 mg, 25 mg, 50 mg, 75 mg, 100 mg